Trancura Biosciences is a biotechnology company that uses targeted genomic approaches for the de nov design of monoclonal antibodies.
Trancura Biosciences has raised $972K in total funding. The most recent round was Seed. The last funding was announced in January 2022.
Trancura Biosciences is headquartered in Emeryville, United States.
Trancura Biosciences is a biotechnology company that uses targeted genomic approaches for the de nov design of monoclonal antibodies.
Trancura Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Trancura Biosciences — Funding & Investors." VCBacked, January 7, 2022, https://www.vcbacked.co/company/trancura-biosciences. Accessed September 30, 2026.
VCBacked. (2022). Trancura Biosciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/trancura-biosciences
{{cite web |title=Trancura Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/trancura-biosciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated